Literature DB >> 1799396

Relative protection from cerebral atherosclerosis of young patients with homozygous familial hypercholesterolemia.

A Postiglione1, A Nappi, A Brunetti, A Soricelli, P Rubba, A Gnasso, M Cammisa, V Frusciante, C Cortese, M Salvatore.   

Abstract

It is well known that hypercholesterolemia is correlated with coronary atherosclerosis, but no definite information is available on its association with cerebrovascular atherosclerosis. We studied 10 young patients (age 3-32 years) with homozygous familial hypercholesterolemia (FH), together with 3 normal relatives as healthy controls. Extra- and intracranial Doppler examination, MRI and cerebral blood flow by SPECT and 99mTc-HM-PAO were performed on all. Six out of 10 patients already had signs and symptoms of coronary heart disease, but all patients were free from ischemic brain lesions, as small as detectable at MRI, and had normal cerebral blood flow. Two patients presented significant stenosis of the carotid arteries at Doppler examination. Young patients with homozygous FH have early and clinically evident coronary atherosclerosis, while overt disease in the cerebral district is delayed despite the extremely elevated plasma cholesterol concentration. This was also confirmed by the autopsy of two patients, who died after the study and whose cerebral arteries were totally free from atherosclerotic lesions. The age, at which flow-reducing atherosclerotic lesions develop in hypercholesterolemic patients, differs with regard to the arterial district involved.

Entities:  

Mesh:

Year:  1991        PMID: 1799396     DOI: 10.1016/0021-9150(91)90240-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Geidy Serrano; Holly A Shill; Douglas G Walker; LihFen Lue; Alex E Roher; Brittany N Dugger; Chera Maarouf; Alex C Birdsill; Anthony Intorcia; Megan Saxon-Labelle; Joel Pullen; Alexander Scroggins; Jessica Filon; Sarah Scott; Brittany Hoffman; Angelica Garcia; John N Caviness; Joseph G Hentz; Erika Driver-Dunckley; Sandra A Jacobson; Kathryn J Davis; Christine M Belden; Kathy E Long; Michael Malek-Ahmadi; Jessica J Powell; Lisa D Gale; Lisa R Nicholson; Richard J Caselli; Bryan K Woodruff; Steven Z Rapscak; Geoffrey L Ahern; Jiong Shi; Anna D Burke; Eric M Reiman; Marwan N Sabbagh
Journal:  Neuropathology       Date:  2015-01-26       Impact factor: 1.906

2.  Hyperlipidemia disrupts cerebrovascular reflexes and worsens ischemic perfusion defect.

Authors:  Cenk Ayata; Hwa Kyoung Shin; Ergin Dileköz; Dmitriy N Atochin; Satoshi Kashiwagi; Katharina Eikermann-Haerter; Paul L Huang
Journal:  J Cereb Blood Flow Metab       Date:  2013-03-13       Impact factor: 6.200

3.  Rabbit models of intracranial atherosclerotic disease for pathological validation of vessel wall MRI.

Authors:  J Scott McNally; Adam de Havenon; Seong-Eun Kim; Chuanzhuo Wang; Shuping Wang; Matthew S Zabriskie; Dennis L Parker; Hediyeh Baradaran; Matthew D Alexander
Journal:  Neuroradiol J       Date:  2020-12-16

4.  Apolipoprotein E knockout rabbit model of intracranial atherosclerotic disease.

Authors:  Matthew S Zabriskie; Chuanzhuo Wang; Shuping Wang; Matthew D Alexander
Journal:  Animal Model Exp Med       Date:  2020-06-21

5.  MRI at 3 Tesla detects no evidence for ischemic brain damage in intensively treated patients with homozygous familial hypercholesterolemia.

Authors:  Stephan A Schmitz; Declan P O'Regan; Julie Fitzpatrick; Clare Neuwirth; Elizabeth Potter; Isabella Tosi; Joseph V Hajnal; Rossi P Naoumova
Journal:  Neuroradiology       Date:  2007-07-21       Impact factor: 2.804

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.